Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Propionate for Post-Transplant Constrictive Bronchiolitis
NCT00656916Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2008
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone propionate nasal spray in constrictive bronchiolitis (BO), sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2008; status: terminated.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
constrictive bronchiolitis (BO)
Beyond the preview
Go deeper on NCT00656916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656916.